Supplemental material, sj-docx-1-tam-10.1177_17588359221128356 for Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations by Chenfei Chi, Jiazhou Liu, Liancheng Fan, Yinjie Zhu, Yanqing Wang, Jianjun Sha, Yiran Huang, Baijun Dong, Jiahua Pan and Wei Xue in Therapeutic Advances in Medical Oncology</p
Supplemental material, sj-docx-1-tam-10.1177_17588359231220506 for Nomogram to predict the presence ...
Supplemental material, sj-doc-2-tam-10.1177_17588359231225035 for Reclassification of RAS/BRAF allel...
Supplemental material, sj-docx-1-jbm-10.1177_17246008211034178 for Circ_0006174 promotes colorectal ...
Supplemental material, sj-docx-1-tam-10.1177_17588359231221343 for Combined pre-treatment and middle...
Supplemental material, sj-docx-3-tct-10.1177_15330338221139981 for BCL6-SPECC1L: A Novel Fusion Gene...
Supplemental material, sj-docx-3-tam-10.1177_17588359231225038 for Analysis of circulating tumor DNA...
Supplemental material, sj-docx-1-tag-10.1177_17562848221137758 for Adjuvant chemotherapy improves su...
Supplemental material, sj-docx-1-cix-10.1177_11769351221136056 for Optimizing Drug Response Study De...
Supplemental material, sj-docx-1-tam-10.1177_17588359221148541 for Atezolizumab plus bevacizumab in ...
Supplemental material, sj-docx-1-tam-10.1177_17588359231220516 for TQB2450 in patients with advanced...
Supplemental material, sj-doc-1-tag-10.1177_17562848221117875 for Clinical significance of adjuvant ...
Supplemental material, sj-docx-1-tam-10.1177_17588359211035983 for Real-world efficacy and safety of...
Supplemental material, sj-docx-1-npx-10.1177_1934578X221126964 for A Study on the Mechanism of Herba...
Supplemental material, sj-docx-3-tag-10.1177_17562848221124029 for ‘FLARE’ of tumor marker in advanc...
Supplemental material, sj-docx-1-tam-10.1177_17588359231220501 for Endocrine therapy plus HER2-targe...
Supplemental material, sj-docx-1-tam-10.1177_17588359231220506 for Nomogram to predict the presence ...
Supplemental material, sj-doc-2-tam-10.1177_17588359231225035 for Reclassification of RAS/BRAF allel...
Supplemental material, sj-docx-1-jbm-10.1177_17246008211034178 for Circ_0006174 promotes colorectal ...
Supplemental material, sj-docx-1-tam-10.1177_17588359231221343 for Combined pre-treatment and middle...
Supplemental material, sj-docx-3-tct-10.1177_15330338221139981 for BCL6-SPECC1L: A Novel Fusion Gene...
Supplemental material, sj-docx-3-tam-10.1177_17588359231225038 for Analysis of circulating tumor DNA...
Supplemental material, sj-docx-1-tag-10.1177_17562848221137758 for Adjuvant chemotherapy improves su...
Supplemental material, sj-docx-1-cix-10.1177_11769351221136056 for Optimizing Drug Response Study De...
Supplemental material, sj-docx-1-tam-10.1177_17588359221148541 for Atezolizumab plus bevacizumab in ...
Supplemental material, sj-docx-1-tam-10.1177_17588359231220516 for TQB2450 in patients with advanced...
Supplemental material, sj-doc-1-tag-10.1177_17562848221117875 for Clinical significance of adjuvant ...
Supplemental material, sj-docx-1-tam-10.1177_17588359211035983 for Real-world efficacy and safety of...
Supplemental material, sj-docx-1-npx-10.1177_1934578X221126964 for A Study on the Mechanism of Herba...
Supplemental material, sj-docx-3-tag-10.1177_17562848221124029 for ‘FLARE’ of tumor marker in advanc...
Supplemental material, sj-docx-1-tam-10.1177_17588359231220501 for Endocrine therapy plus HER2-targe...
Supplemental material, sj-docx-1-tam-10.1177_17588359231220506 for Nomogram to predict the presence ...
Supplemental material, sj-doc-2-tam-10.1177_17588359231225035 for Reclassification of RAS/BRAF allel...
Supplemental material, sj-docx-1-jbm-10.1177_17246008211034178 for Circ_0006174 promotes colorectal ...